Solvay Stock: Shares Fall Ahead of 2025 Annual Results Release

Recent Performance and Technical Analysis

Solvay's stock has dropped by 1.92% compared to the previous day, extending a negative streak of more than 3% over the last seven days. The stock is now just below its 200-day moving average, located at 27.89 euros, a technical level often considered as a long-term trend indicator. As long as the price remains below this threshold, the underlying momentum remains weak. The RSI, which measures the relative strength of the stock over 14 days, stands at 65, a zone still far from overheating but indicating some exhaustion of the rebound observed in recent weeks, having recently crossed its 20 and 50-day moving averages (at 26.44 and 26.76 euros respectively). Over the year, the underperformance reaches 16.69%, highlighting the challenges faced by the group in an unpropitious sector environment. The next resistance level is identified at 28.50 euros, a level that must be reclaimed to consider a more sustained reversal of the trend.

Financial Calendar and Key Dates

The financial calendar of the Belgian chemist includes the publication of its 2025 annual results on February 24, which is next Tuesday. This deadline constitutes the first major milestone of the year for the group's shareholders, who completed the spin-off with Syensqo at the end of 2023 and have since continued its strategy focused on essential chemistry. Beyond this publication, several dates will mark the first half of the year: the results of the first quarter of 2026 are expected on May 7, followed by the general meeting scheduled for May 12. These events will allow for an assessment of the group's operational and financial trajectory in a context of uncertain industrial demand in Europe. The stock displays a particularly low beta, at 0.07, indicating a very limited correlation with general market movements and a contained volatility profile, with monthly volatility standing at 9.27%.